Section Arrow
VYGR.NASDAQ
- Voyager Therapeutics
Quotes are at least 15-min delayed:2025/07/26 21:31 EDT
Regular Hours
Last
 3.24
-0.07 (-2.11%)
Day High 
3.375 
Prev. Close
3.31 
1-M High
3.72 
Volume 
581.88K 
Bid
3.17
Ask
3.38
Day Low
3.215 
Open
3.34 
1-M Low
2.83 
Market Cap 
183.16M 
Currency USD 
P/E 6.15 
%Yield -- 
10-SMA 3.26 
20-SMA 3.22 
50-SMA 3.19 
52-W High 9.55 
52-W Low 2.645 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.46/-1.28
Enterprise Value
219.66M
Balance Sheet
Book Value Per Share
4.93
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
80.00M
Operating Revenue Per Share
2.86
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0596+0.0056+10.37%-- 
ABPAbpro Holdings Inc0.3154+0.0493+18.53%-- 
PHIOPhio Pharmaceuticals Corp2.74+0.23+9.16%0.01PE
TNFATNF Pharmaceuticals Inc.0.1168-0.0152-11.52%-- 
IOVAIovance Biotherapeutics3.13-0.16-4.86%-- 
Quotes are at least 15-min delayed:2025/07/26 21:31 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.